Total Payments
$423.11
2021 Payments
$14.96
Companies
11
Transactions
18
Medicare Patients
1,968
Medicare Billing
$284,137
Payment Breakdown by Category
Food & Beverage$423.11 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $423.11 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $85.00 | 1 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $78.19 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $49.36 | 3 | $0 (2017) |
| PFIZER INC. | $45.58 | 3 | $0 (2018) |
| Gilead Sciences, Inc. | $43.45 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $33.76 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $32.20 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $18.02 | 1 | $0 (2018) |
| Allergan Inc. | $13.64 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.59 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $14.96 | 1 | Janssen Pharmaceuticals, Inc ($14.96) |
| 2019 | $89.28 | 4 | Gilead Sciences, Inc. ($43.45) |
| 2018 | $195.54 | 5 | Alkermes, Inc. ($85.00) |
| 2017 | $123.33 | 8 | E.R. Squibb & Sons, L.L.C. ($49.36) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.45 | General |
| 04/15/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/22/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $63.24 | General |
| Category: pseudobulbar affect PBA | ||||||
| 09/25/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/20/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEPHROLOGY | ||||||
| 09/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), PRAXBIND | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $85.00 | General |
| Category: CNS | ||||||
| 08/22/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/10/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.57 | General |
| Category: Cardiovascular | ||||||
| 02/28/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: Cardiovascular | ||||||
| 01/24/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 274 | 701 | $122,810 | $50,612 |
| 2022 | 5 | 259 | 648 | $128,645 | $49,396 |
| 2021 | 11 | 733 | 1,154 | $405,774 | $92,001 |
| 2020 | 11 | 702 | 1,197 | $406,316 | $92,128 |
Total Patients
1,968
Total Services
3,700
Medicare Billing
$284,137
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 480 | $69,120 | $29,736 | 43.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 69 | $18,906 | $6,573 | 34.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 65 | 73 | $15,476 | $6,509 | 42.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 44 | $9,108 | $4,144 | 45.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $8,040 | $2,744 | 34.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 15 | $2,160 | $905.49 | 41.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 69 | 241 | $49,887 | $19,328 | 38.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 279 | $40,176 | $15,918 | 39.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 56 | $22,512 | $8,073 | 35.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 52 | 59 | $12,508 | $4,786 | 38.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $3,562 | $1,291 | 36.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 212 | 498 | $132,937 | $29,725 | 22.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 99 | 100 | $72,564 | $16,753 | 23.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 92 | 193 | $70,567 | $16,643 | 23.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 109 | 110 | $42,352 | $9,618 | 22.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 39 | 39 | $26,149 | $5,966 | 22.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $14,044 | $3,003 | 21.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 44 | 45 | $12,150 | $2,669 | 22.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 44 | 44 | $11,880 | $2,596 | 21.9% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 28 | 37 | $10,027 | $2,243 | 22.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 26 | 48 | $7,056 | $1,421 | 20.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 12 | 12 | $6,048 | $1,364 | 22.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 241 | 651 | $175,885 | $40,038 | 22.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 80 | 80 | $60,000 | $13,410 | 22.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 73 | 134 | $51,590 | $11,967 | 23.2% |
About Dr. Mohammad Sheikh, M.D
Dr. Mohammad Sheikh, M.D is a Internal Medicine healthcare provider based in Parrish, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1285940452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Sheikh, M.D has received a total of $423.11 in payments from pharmaceutical and medical device companies, with $14.96 received in 2021. These payments were reported across 18 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($423.11).
As a Medicare-enrolled provider, Sheikh has provided services to 1,968 Medicare beneficiaries, totaling 3,700 services with total Medicare billing of $284,137. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Parrish, FL
- Active Since 08/26/2010
- Last Updated 01/26/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285940452
Products in Payments
- Aristada 441 mg (Drug) $85.00
- NUEDEXTA (Drug) $78.19
- ELIQUIS (Drug) $49.36
- CHANTIX (Drug) $45.58
- XARELTO (Drug) $32.20
- UTIBRON (Drug) $18.43
- SAMSCA (Drug) $18.02
- BROVANA (Drug) $15.33
- TEFLARO (Drug) $13.64
- PRADAXA (Drug) $12.59
- BRILINTA (Drug) $11.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parrish
Dr. Thomas Zolkos, M.d, M.D
Internal Medicine — Payments: $635.97
Internal Medicine $635.97
Rozina Idrees, M.d, M.D
Internal Medicine — Payments: $609.43
Internal Medicine $609.43
Klaudio Alla, Md, MD
Internal Medicine — Payments: $104.57
Internal Medicine $104.57
Dr. Mark Nickels, M.d, M.D
Internal Medicine — Payments: $61.30
Internal Medicine $61.30
Dr. Shayne Moyles, D.o, D.O
Internal Medicine
Internal Medicine
Joseph Lindley, D.o, D.O
Internal Medicine
Internal Medicine